Skip to main content

Want a detailed portfolio tracker?

IMMX
NASDAQ
$8.80

Immix Biopharma Inc (IMMX)

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology and inflammation in the United States and Australia. The company is headquartered in Los Angeles, California.
Website: https://www.immixbio.com
Sector:
Healthcare
Industry:
Biotechnology
68 analysts
Strong Buy
Target: $19.75 (+124.43%)

Market Cap

$558M

Free Cash Flow Yield

-5.87%

Beta (5Y)

1.23

Price Chart

Valuation
Market Cap$558M
P/B9.01
Profitability
EBITDA-$54M
EPS-$1.21
Financial Health
Free Cash Flow Yield-5.87%
Growth & Risk
Beta (5Y)1.23
Sharpe Ratio1.67